Benazepril Hydrochloride and Hydrochlorothiazide NDC 62559-414

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-414Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0414Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-414-01	62559041401	100 TABLET in 1 BOTTLE (62559-414-01)Marketed from Nov 7, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Benazepril Hydrochloride and Hydrochlorothiazide
Generic name (nonproprietary): benazepril hydrochloride and hydrochlorothiazide
Active ingredients: Benazepril hydrochloride — 5 mg/1Hydrochlorothiazide — 6.25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076342
Marketing start: Nov 7, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 62559-414_052493c7-89a3-452e-8140-04dd95f0d9e2SPL ID 052493c7-89a3-452e-8140-04dd95f0d9e2SPL set ID e6527adf-8c74-4d81-9199-d56a7fca895eRxCUI 898362, 898367, 898372, 898378UNII N1SN99T69T, 0J48LPH2THUPC 0362559415019, 0362559416016, 0362559414012, 0362559417013
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559041401 followed by a unit qualifier and the quantity

Package 62559-0414-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Benazepril hydrochloride and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension. This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION ) .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076342

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076342
Product	Strength	Form · route	Labeler	Product NDC
Benazepril Hydrochloride and Hydrochlorothiazide	Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-417
Benazepril Hydrochloride and Hydrochlorothiazide	Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-415
Benazepril Hydrochloride and Hydrochlorothiazide	Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	62559-416